Isoplexis (ISO) Inventory Turnover Ratio, from fourth quarter 2022 to fourth quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Isoplexis Corporation  (NASDAQ: ISO)
 

Isoplexis Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Isoplexis Corporation inventory turnover ratio, the Isoplexis Corporation's ability to sell and replace its inventory in the fourth quarter 2022, sequentially increased to 0.5 in the fourth quarter 2022, a new company high. Average inventory processing period, for the Isoplexis in Dec 31 2022 quarter, has decreased to 730 days, compare to 1460 days, in the Sep 30 2022 quarter.

Within Healthcare sector 426 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 2026 in the third quarter 2022, to 2051.

ISO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Isoplexis Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ISO Inventory Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Inventory Growth 13.24 % 89.04 % 885.79 % - -
Y / Y Cost of Sales Growth 404.03 % -0.91 % - - -
Inventory Turnover Ratio (TTM) 0.5 0.25 0.29 0.33 0.36
ISO's Total Ranking # 2051 # 2026 # 2038 # 2030 # 2003
Average inventory processing period 728 1454 1259 1123 1002
Seq. Inventory Growth -28.06 % -1.9 % 13 % 42 % 20.1 %
Seq. Cost of Sales Growth 408.64 % 20.63 % -22.16 % 5.53 % 0 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 28
Healthcare Sector # 427
Overall Market # 2051

Inventory Turnover Ratio Statistics
High Average Low
0.5 0.31 0.18
(Dec 31 2022)   (Dec 31 2021)



ISO Company Profile >> Back to ISO Efficiency Comparisons >> Compare ISO Inventory Turnover Ratio to its Competitors

Financial Statements
Isoplexis's Inventories $ 28 Millions Visit ISO's Balance sheet
Isoplexis's Cost of Revenues TTM $ 17 Millions Visit ISO's Income Statement
What are ISO's Sales? Visit ISO's Sales by Segment

Other Inventory Turnover Ratios
Isoplexis's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ISO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ISO's Competitors
Inventory Turnover Ratio for ISO's Suppliers
Inventory Turnover Ratio for ISO's Customers

You may also want to know
ISO's Sales Growth Rates ISO's Pe Price to earnings ratio ISO's Receivables Turnover Ratio ISO's Stock Quote
ISO's Net Income Growth Rates ISO's Ps Price to Sales ratio ISO's Sales per Employee ISO's Asset Turnover Ratio
ISO's Net Margin ISO's Pb Price to Book ratio ISO's Financial Strength Ratios ISO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2022 Inventories at quarter ending Dec 31 2022
Acadia Pharmaceuticals Inc   1.74 $ 10.166  Millions$ 6  Millions
Biogen Inc   1.74 $ 2,278.300  Millions$ 1,307  Millions
Yunhong Green Cti Ltd   1.74 $ 14.910  Millions$ 9  Millions
Ligand Pharmaceuticals Incorporated  1.71 $ 36.673  Millions$ 22  Millions
Anika Therapeutics Inc   1.70 $ 62.660  Millions$ 37  Millions
Pressure Biosciences Inc   1.68 $ 2.014  Millions$ 1  Millions
Therapeutic Solutions International Inc   1.68 $ 0.079  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.67 $ 40.298  Millions$ 24  Millions
Eli Lilly And Company  1.66 $ 6,629.800  Millions$ 3,983  Millions
United Therapeutics Corporation  1.63 $ 151.600  Millions$ 93  Millions
Trevena inc   1.63 $ 3.018  Millions$ 2  Millions
Procyon Corporation  1.62 $ 1.205  Millions$ 1  Millions
10x Genomics Inc   1.61 $ 118.827  Millions$ 74  Millions
Bruker Corporation  1.61 $ 1,225.000  Millions$ 762  Millions
Conmed Corporation  1.61 $ 474.227  Millions$ 295  Millions
Seer Inc   1.61 $ 8.400  Millions$ 5  Millions
Halozyme Therapeutics Inc   1.60 $ 139.304  Millions$ 87  Millions
Whitehawk Therapeutics Inc   1.59 $ 1.401  Millions$ 1  Millions
Nanostring Technologies Inc   1.59 $ 65.475  Millions$ 41  Millions
Taro Pharmaceutical Industries Ltd  1.58 $ 268.212  Millions$ 169  Millions
Thermogenesis Holdings Inc   1.58 $ 7.773  Millions$ 5  Millions
Inari Medical Inc   1.58 $ 44.506  Millions$ 28  Millions
Tenet Healthcare Corp  1.57 $ 620.000  Millions$ 394  Millions
Icad Inc  1.57 $ 8.132  Millions$ 5  Millions
Zomedica Corp   1.56 $ 5.278  Millions$ 3  Millions
Transmedics Group Inc   1.54 $ 28.187  Millions$ 18  Millions
Xtant Medical Holdings Inc   1.53 $ 26.028  Millions$ 17  Millions
Insulet Corporation  1.53 $ 499.700  Millions$ 327  Millions
Apyx Medical Corp  1.52 $ 15.379  Millions$ 10  Millions
Assertio Holdings inc   1.51 $ 18.748  Millions$ 12  Millions

Date modified: 2026-09-08T15:10:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.